Post Prandial Glucose Control Proof-of-Principle
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45249
- Radiant Research
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- type 2 diabetes
- between 21 and 75 years of age
- male or a non-pregnant, non-lactating female, at least 6 weeks postpartum or postmenopausal or surgically sterile
- BMI is > 18.5 kg/m2 and <35 kg/m2
- HbA1c < 9.0%
Exclusion Criteria:
- Subject uses exogenous insulin, exenatide, or sitagliptin phosphate
- type 1 diabetes.
- history of diabetic ketoacidosis.
- current infection
- active malignancy
- has had a significant cardiovascular event or history of congestive heart failure.
- end-stage organ failure or post organ transplant.
- history of renal disease.
- hepatic disease.
- history of gastrointestinal disorders
- chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
- taking any herbals, dietary supplements, or medications, other than oral hypoglycemic medications
- clotting or bleeding disorders.
- allergic or intolerant to any ingredient found in the study products.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: QUADRUPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Nutritional ingredient
Dissolve in water and consume with meal
|
Dissolve in water and consume with meals
|
|
PLACEBO_COMPARATOR: Carbohydrate
dissolve in water and consume with meal
|
dissolve in water and consume with meal
|
|
EXPERIMENTAL: #1 Nutrtitional ingredient + Fiber
Dissolve in water and consume with meal
|
Dissolve in water and consume with meal
|
|
EXPERIMENTAL: #2 Nutritional ingredient + Fiber
Dissolve in water and consume with meal
|
Dissolve in water and consume with meal
|
|
EXPERIMENTAL: #3 Nutritional ingredient + Fiber
Dissolve in water and consume with meal
|
Dissolve in water and consume with meal
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Positive AUC from 0 to 240 minutes for plasma glucose.
Time Frame: 0 to 240 minutes
|
0 to 240 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Plasma glucose concentrations
Time Frame: 0 to 240 minutes
|
0 to 240 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BK92
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.